As previously announced AMDL
received initial re-certification in March 2009 and resumed full product production in July 2009.
Onko-Sure is researched, developed and manufactured in AMDL
Diagnostic's Tustin, California-based facilities and sold to 3rd party distributors, which then sell directly to CLIA-certified reference laboratories in the US as well as clinical reference labs, hospital labs and physician-operated labs in the international market.
More information about AMDL
and its additional products can be obtained at www.
Douglas MacLellan, Chairman and CEO of AMDL
stated, "Over the past six months AMDL
has been executing a very aggressive commercialization strategy for DR-70, which is progressing at a faster pace than originally expected.
Since 2006 AMDL
has achieved more than 100% in year-over-year gross revenue growth and remains on track with its FY2009 business milestones and financial guidance projections.
For the first quarter 2009 AMDL
reported unaudited net revenues of approximately $2.
com/ or contact AMDL
Investor Relations at kszarkowitz@amdl.
as its first customer to offer the AMDL
DR-70 (FDP) in vitro cancer test to patients and doctors in the US.
For the past four consecutive years AMDL
has achieved over 100% year-over-year gross revenue growth.
Through this validation study, AMDL
and Mayo Clinic will perform clinical diagnostic testing to compare AMDL
's DR-70 (FDP) cancer test with a newly developed, next generation test.
Founded in 1987, AMDL
operates three distinct business divisions that include: (i) In Vitro Diagnostics, (ii) Cancer Therapeutics, and (iii) China-based pharmaceutical manufacturing and distribution.
MacLellan was invited as a guest expert on Fox Business News to discuss the Chinese business environment specifically for pharmaceutical and healthcare companies, the Company's outlook for 2009 and its focus on growth in the emerging Chinese market, and how AMDL
is leading the industry as one of the first US-based companies to enforce and implement Westernized business practices -- including SOX-compliant operating procedures and GAAP-certified accounting practices -- across its US and China operations.